Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic ...

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient ...

Widespread use of maternal RSV vaccination and nirsevimab during the 2024–2025 U.S. RSV season led to a significant reduction ...

Far fewer babies went to the hospital struggling to breathe from RSV, a severe respiratory infection, after the debut of a new vaccine and treatment this season, according to an analysis published ...

A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

The antibody treatment also reduced ... tract infections by 75% in children younger than 1 year old, results show. Nirsevimab also was more effective in preventing RSV-related hospitalizations ...

New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the ...